DarioHealth (OTCQB:DRIO) said today it inked a number of private placement offerings totaling $4.3 million in aggregate through the issuance of common stock and Series B convertible preferred stock. The Israel-based company said that current shareholders would account for 54% of the securities to be sold in the offerings, in which the company will issue 483,333 shares […]
DarioHealth Corp
DarioHealth wins FDA nod for Android diabetes app
DarioHealth (OTCQB:DRIO) said yesterday it won FDA 510(k) approval for its Dario diabetes management application on certain Google (NSDQ:GOOG) Android devices. The approval expands the Israel-based company’s availability from exclusively Apple (NSDQ:AAPL) iOS products, which it has had clearance on since winning FDA clearance for its Dario blood glucose monitoring system in December 2015. DarioHealth said the […]
LabStyle Innovations rebrands as DarioHealth
LabStyle Innovations Corp. (OTCQB:DRIO) said today it is rebranding, shifting its corporate moniker to DarioHealth Corp. The Boston-based company said the new name reflects the “company’s growth and development in the digital health and mHealth space,” and added that it will continue to trade on Nasdaq under the ticker “DRIO.” “The healthcare world is changing, and we believe […]